To use or not to use hydroxyethyl starch in intraoperative care: Are we ready to answer the 'Gretchen question'?

Current Opinion in Anaesthesiology

Volumn 28, Issue 3, 2015, Pages 370-377

  Heßler, Michael ^a   Arnemann, Philip Helge ^a   Ertmer, Christian ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

acute kidney injury; fluid therapy; hydroxyethyl starch

Indexed keywords

HETASTARCH; HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE;

ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; BLOOD CLOTTING; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; CRYSTALLOID; DEHYDRATION; ELECTIVE SURGERY; FLUID BALANCE; FLUID RESUSCITATION; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; INTRAOPERATIVE PERIOD; KIDNEY FUNCTION; META ANALYSIS (TOPIC); MICROCIRCULATION; MOLECULAR WEIGHT; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); TISSUE OXYGENATION; TISSUE PERFUSION; ELECTROLYTE BALANCE; FLUID THERAPY; INTENSIVE CARE; PROCEDURES;

CRITICAL CARE; FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; PERIOPERATIVE CARE; PLASMA SUBSTITUTES; WATER-ELECTROLYTE BALANCE;

EID: 84929992903     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000194     Document Type: Review

References (77)

1. Wiedersheim M. An investigation of oxyethylstarch as a new plasma volume expander in animals. Arch Int Pharmacodyn Ther 1957; 111:353-361.
2. Hartog CS, Natanson C, Sun J, et al. Concerns over use of hydroxyethyl starch solutions. BMJ 2014; 349:g5981.
3. De Hert S, De Baerdemaeker L. Why hydroxyethyl starch solutions should NOT be banned from the operating room. Anaesthesiol Intensive Ther 2014; 46:336-341.
4. Kampmeier T, Rehberg S, Ertmer C. Evolution of fluid therapy. Best Pract Res Clin Anaesthesiol 2014; 28:207-216.
5. European Medicines Agency. PRAC confirms that hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients. http://www.ema.europa.eu/ema/index.jsp?curl pages/medicines/human/referrals/Hydroxyethyl-starch-containing-solutions/human-referral-prac-000012.jsp&midWC0b01ac05805c516f. [Accessed 22 November 2014].
6. Jacob M, Chappell D, Hofmann-Kiefer K, et al. [Determinants of insensible fluid loss. Perspiration, protein shift and endothelial glycocalyx]. Anaesthesist 2007; 56:747-758.
7. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345:588-595.
8. Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 2009; 22:155-162.
9. Demling RH. The burn edema process: current concepts. J Burn Care Rehabil 2005; 26:207-227.
10. Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid management. Anesthesiology 2008; 109:723-740.
11. Lamke LO, Liljedahl SO. Plasma volume changes after infusion of various plasma expanders. Resuscitation 1976; 5:93-102.
12. Yates DR, Davies SJ, Milner HE, Wilson RJ. Crystalloid or colloid for goaldirected fluid therapy in colorectal surgery. Br J Anaesth 2014; 112:281-289.
13. Jacob M, Chappell D, Hofmann-Kiefer K, et al. The intravascular volume effect of Ringer's lactate is below 20%: a prospective study in humans. Crit Care 2012; 16:R86.
14. Jacob M, Rehm M, Orth V, et al. [Exact measurement of the volume effect of 6% hydoxyethyl starch 130/0.4 (Voluven) during acute preoperative normovolemic hemodilution]. Anaesthesist 2003; 52:896-904.
15. Baron JF, De Kegel D, Prost AC, et al. Low molecular weight hydroxyethyl starch 6% compared to albumin 4% during intentional hemodilution. Intensive Care Med 1991; 17:141-148.
16. Riddez L, Hahn RG, Brismar B, et al. Central and regional hemodynamics during acute hypovolemia and volume substitution in volunteers. Crit Care Med 1997; 25:635-640.
17. Jacob M, Bruegger D, Rehm M, et al. The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 2007; 73:575-586.
18. Rehm M, Zahler S, Lotsch M, et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004; 100:1211-1223.
19. Rehm M, Haller M, Orth V, et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology 2001; 95:849-856.
20. Jacob M, Bruegger D, Rehm M, et al. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006; 104:1223-1231.
21. Chappell D, Bruegger D, Potzel J, et al. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care 2014; 18:538.
22. Jacob M, Saller T, Chappell D, et al. Physiological levels of A-, B-and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res Cardiol 2013; 108:347.
23. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116:1896-1906.
24. Bruegger D, Schwartz L, Chappell D, et al. Release of atrial natriuretic peptide precedes shedding of the endothelial glycocalyx equally in patients undergoing on-and off-pump coronary artery bypass surgery. Basic Res Cardiol 2011; 106:1111-1121.
25. Steppan J, Hofer S, Funke B, et al. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. J Surg Res 2011; 165:136-141.
26. Hamilton-Davies C, Mythen MG, Salmon JB, et al. Comparison of commonly used clinical indicators of hypovolaemia with gastrointestinal tonometry. Intensive Care Med 1997; 23:276-281.
27. Hofmann-Kiefer K, Chappell D, Jacob M, et al. [Acute perioperative hemodilution without using hydroxyethyl starch: hemodynamic alterations under 'controlled' hypovolemia]. Anaesthesist 2015; 64:26-32.
28. WorkingGroup of the Scientific and Medical Societies (AWMF). Intravascular volume therapy in adults [in German]. http://www.awmf.org/leitlinien/detail/ll/001-020.html [Accessed 28 December 2014].
29. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30:270-382.
30. Brandstrup B, Tønnesen H, Beier-Holgersen R, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 2003; 238:641-648.
31. Wright GP, Koehler TJ, Davis AT, Chung MH. The drowning whipple: perioperative fluid balance and outcomes following pancreaticoduodenectomy. J Surg Oncol 2014; 110:407-411.
32. Lobo DN. Fluid overload and surgical outcome: another piece in the jigsaw. Ann Surg 2009; 249:186-188.
33. Toraman F, Evrenkaya S, Yuce M, et al. Highly positive intraoperative fluid balance during cardiac surgery is associated with adverse outcome. Perfusion 2004; 19:85-91.
34. Arieff AI. Fatal postoperative pulmonary edema: pathogenesis and literature review. Chest 1999; 115:1371-1377.
35. Hassinger AB, Wald EL, Goodman DM. Early postoperative fluid overload precedes acute kidney injury and is associated with higher morbidity in pediatric cardiac surgery patients. Pediatr Crit Care Med 2014; 15:131-138.
36. Barmparas G, Liou D, Lee D, et al. Impact of positive fluid balance on critically ill surgical patients: a prospective observational study. J Crit Care 2014; 29:936-941.
37. Lowell JA, Schifferdecker C, Driscoll DF, et al. Postoperative fluid overload: not a benign problem. Crit Care Med 1990; 18:728-733.
38. Ley EJ, Clond MA, Srour MK, et al. Emergency department crystalloid resuscitation of 1.5 l or more is associated with increased mortality in elderly and nonelderly trauma patients. J Trauma 2011; 70:398-400.
39. Jacob M, Fellahi JL, Chappell D, Kurz A. The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis. Crit Care 2014; 18:656.
40. Hans GA, Ledoux D, Roediger L, et al. The effect of intraoperative 6% balanced hydroxyethyl starch (130/0.4) during cardiac surgery on transfusion requirements. J Cardiothorac Vasc Anesth 2015; 29:328-332.
41. Xia J, He Z, Cao X, et al. The brain relaxation and cerebral metabolism in stroke volume variation-directed fluid therapy during supratentorial tumors resection: crystalloid solution versus colloid solution. J Neurosurg Anesthesiol 2014; 26:320-327.
42. Westphal M, James M2F, Kozek-Langenecker S, et al. Hydroxyethyl starches: different products-different effects. Anesthesiology 2009; 111:187-202.
43. Jungheinrich C. The starch family: are they all equal? Pharmacokinetics and pharmacodynamics of hydroxyethyl starches. Transfus Altern Transfus Med 2007; 9:152-163.
44. Waitzinger J, Bepperling F, Pabst G, Opitz J. Hydroxyethyl starch (HES) 130/0.4, a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers. Drugs R D 2003; 4:149-157.
45. Lehmann GB, Asskali F, Boll M, et al. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly. Br J Anaesth 2007; 98:635-644.
46. Asskali F, Forster H. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers]. Anasthesiol Intensivmed Notfallmed Schmerzther 1999; 34:537-541.
47. Mishler JM, Borberg H, Emerson PM, Gross R. Hydroxyethyl starch: an agent for hypovolemic shock treatment. J Surg Res 1977; 23:239-245.
48. Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg 2002; 95:544-551.
49. Ertmer C, Wulf H, Van Aken H, et al. Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients. Minerva Med 2012; 103:111-122.
50. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-1911.
51. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139.
52. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367:124-134.
53. Vermeer H, Teerenstra S, de Sevaux RG, et al. The effect of hemodilution during normothermic cardiac surgery on renal physiology and function: a review. Perfusion 2008; 23:329-338.
54. Gurbuz HA, Durukan AB, Salman N, et al. Hydroxyethyl starch 6%, 130/0.4 vs. A balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study. J Cardiothorac Surg 2013; 8:71.
55. Akkucuk FG, Kanbak M, Ayhan B, et al. The effect of HES (130/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery. Ren Fail 2013; 35:210-215.
56. Van der Linden P, De Ville A, Hofer A, et al. Six percentage hydroxyethyl starch 130/0.4 (Voluven) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in paediatric patients. Anesthesiology 2013; 119:1296-1309.
57. Miao N, Yang J, Du Z, et al. Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgery. Perfusion 2014; 29:462-468.
58. Kancir AS, Pleckaitiene L, Hansen TB, et al. Lack of nephrotoxicity by 6% hydroxyethyl starch 130/0.4 during hip arthroplasty: a randomized controlled trial. Anesthesiology 2014; 121:948-958.
59. Haase M, Story DA, Haase-Fielitz A. Renal injury in the elderly: diagnosis, biomarkers and prevention. Best Pract Res Clin Anaesthesiol 2011; 25:401-412.
60. Singer E, Marko L, Paragas N, et al. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf) 2013; 207:663-672.
61. Feldheiser A, Pavlova V, Bonomo T, et al. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth 2013; 110:231-240.
62. Martin C, Jacob M, Vicaut E, et al. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013; 118:387-394.
63. Gillies MA, Habicher M, Jhanji S, et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth 2014; 112:25-34.
64. Kashy BK, Podolyak A, Makarova N, et al. Effect of hydroxyethyl starch on postoperative kidney function in patients having noncardiac surgery. Anesthesiology 2014; 121:730-739.
65. Wilkes M, Navickis R. Postoperative renal replacement therapy after hydroxyethyl starch infusion: a meta-analysis of randomised trials. Neth J Crit Care 2014; 18:1-9.
66. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005; 103:654-660.
67. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008; 107:382-390.
68. Hartog CS, Reuter D, Loesche W, et al. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 2011; 37:1725-1737.
69. Lison S, Weiss G, Spannagl M, Heindl B. Postoperative changes in procoagulant factors after major surgery. Blood Coagul Fibrinolysis 2011; 22:190-196.
70. Falanga A. Mechanisms of hypercoagulation in malignancy and during chemotherapy. Haemostasis 1998; 28 (Suppl 3):50-60.
71. Hung MH, Zou C, Lin FS, et al. New 6% hydroxyethyl starch 130/0.4 does not increase blood loss during major abdominal surgery: a randomized, controlled trial. J Formos Med Assoc 2014; 113:429-435.
72. Rasmussen KC, Johansson PI, Højskov M, et al. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial. Ann Surg 2014; 259:249-254.
73. Xu J, Ma L, Sun S, et al. Fluid resuscitation guided by sublingual partial pressure of carbon dioxide during hemorrhagic shock in a porcine model. Shock 2013; 39:361-365.
74. Pearse RM, Moreono RP, Bauer P, et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet 2012; 380:1059-1065.
75. Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 2013; 119:507-515.
76. Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg 2013; 116:35-48.
77. von Goethe JW. Faust. Fragment. 1st edition. Leipzig, Germany: published by G. J. Gö schen; 1790; 136.